4.3 Article

Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?

C. Ibanez et al.

Summary: In COVID-19 patients, a hypercoagulable state with decreased fibrinolytic capacity is observed in ROTEM profiles despite increased D-dimer levels, suggesting lungs may be the main source of D-dimer while a systemic hypofibrinolytic state coexists. Future studies should confirm this hypothesis.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Article Hematology

Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis

Filip Ionescu et al.

Summary: The study found that higher doses of anticoagulants were associated with lower mortality in hospitalized COVID-19 patients. Both therapeutic and prophylactic doses of anticoagulants were shown to reduce the risk of death, but patients receiving therapeutic anticoagulants were more prone to major bleeding.

EUROPEAN JOURNAL OF HAEMATOLOGY (2021)

Review Hematology

Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis

Noppacharn Uaprasert et al.

Summary: Systemic coagulopathy in patients with COVID-19 is relatively low, despite elevated D-dimer levels in most patients. Average levels of D-dimer and fibrinogen are significantly increased, while platelet counts, PT, and aPTT ratios are minimally affected in COVID-19.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)

Review Hematology

Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Toshiaki Iba et al.

Summary: There may be differences in thrombosis and bleeding among different ethnicities in COVID-19 patients, with a lower incidence of thromboembolic events in the Asian population. Despite bleeding being a side effect, current evidence supports routine anticoagulant use and thromboprophylaxis using a standard dose of LMWH for admitted patients.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)

Article Medicine, General & Internal

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama et al.

Summary: Among hospitalized patients with Covid-19 pneumonia not on mechanical ventilation, tocilizumab reduced the risk of progression to mechanical ventilation or death, but did not improve overall survival. There were no new safety concerns identified.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Hematology

Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis

Rushad Patell et al.

Summary: The study found that hospitalized COVID-19 patients who received pharmacologic thromboprophylaxis had lower rates of thrombosis. Patients receiving intermediate-dose thromboprophylaxis or therapeutic anticoagulation had similar rates of thrombosis and bleeding compared to those who received standard-dose pharmacologic thromboprophylaxis.

THROMBOSIS AND HAEMOSTASIS (2021)

Letter Surgery

Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience

Giovanna Travi et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Surgery

Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection

Franklin L. Wright et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)

Article Hematology

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Jean-Francois Llitjos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Incidence of venous thromboembolism in hospitalized patients with COVID-19

Saskia Middeldorp et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Songping Cui et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome

Marco Ranucci et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Cardiac & Cardiovascular Systems

The association between treatment with heparin and survival in patients with Covid-19

Luis Ayerbe et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Article Critical Care Medicine

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

Sharon E. Fox et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Medicine, General & Internal

Severe Covid-19

David A. Berlin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Critical Care Medicine

Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019

Eugene Yuriditsky et al.

CRITICAL CARE MEDICINE (2020)

Article Pharmacology & Pharmacy

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

Pasquale Paolisso et al.

FRONTIERS IN PHARMACOLOGY (2020)

Letter Cardiac & Cardiovascular Systems

Heparin-Induced Thrombocytopenia in Severe COVID-19

Florence Daviet et al.

CIRCULATION (2020)

Article Medicine, General & Internal

Association of Padua prediction score with in-hospital prognosis in COVID-19 patients

D. X. Zeng et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Girish N. Nadkarni et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Letter Cardiac & Cardiovascular Systems

The role of cardiologists in the coronavirus disease 2019 pandemic

Francesco Fedele et al.

KARDIOLOGIA POLSKA (2020)

Editorial Material Medicine, General & Internal

Anticoagulation in Hospitalized Patients with Covid-19

Jehan F. Chowdhury et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

Baranca Buijsers et al.

EBIOMEDICINE (2020)

Meeting Abstract Hematology

Heparin Induced Thrombocytopenia in Patients with COVID-19

Surbhi Warrior et al.

Review Biochemistry & Molecular Biology

Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction

Paolo Severino et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Hematology

Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis

Stephan Nopp et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Health Policy & Services

Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis

Farha Musharrat Noor et al.

JOURNAL OF COMMUNITY HEALTH (2020)

Review Rheumatology

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

Dennis McGonagle et al.

LANCET RHEUMATOLOGY (2020)

Review Hematology

Using heparin molecules to manage COVID-2019

Jian Liu et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Obstetrics & Gynecology

Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study

Rebecca A. M. Pierce-Williams et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2020)

Article Medicine, General & Internal

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

Alexander T. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Hematology

Heparin-Induced Thrombocytopenia in Critically Ill Patients

Theodore E. Warkentin

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)

Article Health Care Sciences & Services

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Xiang Wan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2014)

Letter Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients REPLY

Alexander T. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

Alexander T. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

Samuel Z. Goldhaber et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Article Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

ANNALS OF INTERNAL MEDICINE (2009)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Article Medicine, General & Internal

Bias and causal associations in observational research

DA Grimes et al.

LANCET (2002)